• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肝癌细胞系中因子XIII B亚基的生物合成

Biosynthesis of factor XIII B subunit by human hepatoma cell lines.

作者信息

Nagy J A, Henriksson P, McDonagh J

出版信息

Blood. 1986 Dec;68(6):1272-9.

PMID:3022846
Abstract

The plasma transglutaminase, factor XIIIa (FXIIIa), circulates as a zymogen containing two proteins, A and B, arranged in a noncovalent tetrameric complex, A2B2. Biosynthesis of plasma FXIII has not previously been demonstrated. In the present study, direct evidence has been obtained that two human hepatoma cell lines, Hep G2 and PLC/PRF/5, synthesize and secrete FXIII B protein. Secretion of the B subunit of FXIII by Hep G2 was demonstrated by immunoblotting. De novo synthesis by Hep G2 was confirmed in 35S-methionine-labeled cultures. Radiolabeled conditioned medium was concentrated, mixed (1:1) with purified B protein, and examined by crossed immunoelectrophoresis with antiserum to the B subunit. The single protein precipitin arc of purified B protein comigrated with the radiolabeled FXIII from Hep G2 visualized by autoradiography, indicating both electrophoretic and antigenic identity. The data presented here represent the first demonstrations of biosynthesis of FXIII B protein by any cell type and suggest that the liver is the site of synthesis of FXIII B protein. Further analysis of concentrated Hep G2 serum-free conditioned medium (SFCM) and cell lysate by immunoblotting following nondenaturing agarose gel electrophoresis demonstrated the FXIII A protein as well as the B protein and also revealed synthesis and secretion of the A and B proteins by PLC/PRF/5. Crossed immunoelectrophoresis studies of Hep G2 SFCM and cell lysate suggest that Hep G2 cells also synthesize and secrete the plasma FXIII zymogen. With a specific radioimmunoassay for B protein, FXIII was found in Hep G2 SFCM at approximately 4 ng/mL; with an amplified rocket immunoelectrophoresis technique the level was approximately 5 ng/mL.

摘要

血浆转谷氨酰胺酶,即因子ⅩⅢa(FXIIIa),以一种酶原形式循环,它包含两种蛋白质A和B,以非共价四聚体复合物A2B2的形式排列。此前尚未证实血浆FXIII的生物合成。在本研究中,已获得直接证据表明,两种人肝癌细胞系,即Hep G2和PLC/PRF/5,能够合成并分泌FXIII B蛋白。通过免疫印迹法证实了Hep G2分泌FXIII的B亚基。在35S-甲硫氨酸标记的培养物中证实了Hep G2的从头合成。将放射性标记的条件培养基浓缩,与纯化的B蛋白按1:1混合,并用抗B亚基抗血清进行交叉免疫电泳检测。纯化B蛋白的单一蛋白质沉淀弧与通过放射自显影观察到的来自Hep G2的放射性标记FXIII迁移一致,表明两者在电泳和抗原性上相同。此处呈现的数据首次证明了任何细胞类型均可生物合成FXIII B蛋白,并提示肝脏是FXIII B蛋白的合成部位。通过非变性琼脂糖凝胶电泳后免疫印迹法对浓缩的Hep G2无血清条件培养基(SFCM)和细胞裂解物进行进一步分析,证实了FXIII A蛋白以及B蛋白的存在,同时也揭示了PLC/PRF/5合成并分泌A蛋白和B蛋白。对Hep G2 SFCM和细胞裂解物进行的交叉免疫电泳研究表明,Hep G2细胞也能合成并分泌血浆FXIII酶原。通过针对B蛋白的特异性放射免疫测定法,在Hep G2 SFCM中检测到FXIII的含量约为4 ng/mL;采用放大火箭免疫电泳技术,该水平约为5 ng/mL。

相似文献

1
Biosynthesis of factor XIII B subunit by human hepatoma cell lines.人肝癌细胞系中因子XIII B亚基的生物合成
Blood. 1986 Dec;68(6):1272-9.
2
Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines.已建系的人肝细胞系对α2-纤溶酶抑制剂的合成与分泌
Proc Natl Acad Sci U S A. 1982 Sep;79(18):5684-7. doi: 10.1073/pnas.79.18.5684.
3
Biosynthesis of plasma factor XIII: evidence for transcription and translation in hepatoma cells.血浆因子 XIII 的生物合成:肝癌细胞中转录和翻译的证据。
Biochim Biophys Acta. 1995 Feb 22;1247(1):127-34. doi: 10.1016/0167-4838(94)00167-f.
4
Fibronectin synthesized by a human hepatoma cell line.由人肝癌细胞系合成的纤连蛋白。
Cancer Res. 1984 Jul;44(7):3022-8.
5
Studies on the synthesis and secretion of transthyretin by the human hepatoma cell line Hep G2.人肝癌细胞系Hep G2中甲状腺素运载蛋白的合成与分泌研究。
FEBS Lett. 1991 Aug 5;287(1-2):193-6. doi: 10.1016/0014-5793(91)80049-9.
6
Synthesis and secretion of protein C inhibitor by the human hepatoma-derived cell line, Hep G2.人肝癌衍生细胞系Hep G2对蛋白C抑制剂的合成与分泌
Biochim Biophys Acta. 1985 Feb 21;844(2):209-15. doi: 10.1016/0167-4889(85)90092-8.
7
Biosynthesis of a novel thyroxine-binding protein (27K protein) in human hepatoma (Hep G2) cells.人肝癌(Hep G2)细胞中一种新型甲状腺素结合蛋白(27K蛋白)的生物合成
Endocrinology. 1986 Jun;118(6):2370-4. doi: 10.1210/endo-118-6-2370.
8
Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.转谷氨酰胺酶(因子 XIII)介导的纤维蛋白原和纤维蛋白交联。
Thromb Haemost. 2001 Nov;86(5):1221-8.
9
Down-regulation of insulin-like growth factor binding proteins and growth modulation in hepatoma cells by retinoic acid.视黄酸对肝癌细胞中胰岛素样生长因子结合蛋白的下调作用及生长调节
Hepatology. 1999 Apr;29(4):1091-8. doi: 10.1002/hep.510290414.
10
The Plasma Factor XIII Heterotetrameric Complex Structure: Unexpected Unequal Pairing within a Symmetric Complex.血浆因子 XIII 四聚体复合物结构:在对称复合物中出现意想不到的不等配对。
Biomolecules. 2019 Nov 21;9(12):765. doi: 10.3390/biom9120765.

引用本文的文献

1
Expression of factor XIII originating from synovial fibroblasts and macrophages induced by interleukin-6 signaling.白细胞介素-6信号诱导的滑膜成纤维细胞和巨噬细胞来源的凝血因子XIII的表达。
Inflamm Regen. 2023 Jan 6;43(1):2. doi: 10.1186/s41232-022-00252-4.
2
Disruption of Structural Disulfides of Coagulation FXIII-B Subunit; Functional Implications for a Rare Bleeding Disorder.凝血因子 XIII-B 亚基结构中二硫键的破坏;对一种罕见出血性疾病的功能影响。
Int J Mol Sci. 2019 Apr 22;20(8):1956. doi: 10.3390/ijms20081956.
3
Factor XIII Subunit A in the Skin: Applications in Diagnosis and Treatment.
皮肤中的因子 XIII 亚单位 A:在诊断和治疗中的应用。
Biomed Res Int. 2017;2017:3571861. doi: 10.1155/2017/3571861. Epub 2017 Aug 15.
4
Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?卡曲凝血酶原复合物:先天性因子ⅩⅢ A亚基缺乏症治疗的突破?
J Blood Med. 2014 Jul 9;5:107-13. doi: 10.2147/JBM.S35395. eCollection 2014.
5
Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.托珠单抗诱导类风湿关节炎患者获得性因子 XIII 缺乏症。
PLoS One. 2013 Aug 1;8(8):e69944. doi: 10.1371/journal.pone.0069944. Print 2013.
6
Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice.给因子XIII B亚基基因敲除小鼠注射因子XIII B亚基可提高血浆因子XIII A亚基水平。
Int J Hematol. 2008 Jan;87(1):60-8. doi: 10.1007/s12185-007-0005-z. Epub 2007 Dec 5.
7
Roles of transglutaminases in cardiac and vascular diseases.转谷氨酰胺酶在心脏和血管疾病中的作用。
Front Biosci. 2007 Jan 1;12:2530-45. doi: 10.2741/2253.
8
Population pharmacokinetics of recombinant factor XIII in cynomolgus monkeys.重组因子 XIII 在食蟹猴体内的群体药代动力学。
AAPS J. 2005 Oct 27;7(3):E693-703. doi: 10.1208/aapsj070370.